Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia

Affiliations

• ¹ EA3518, Institut Universitaire d'Hématologie (IUH), University Paris Diderot, France Hematology, Centre Hospitalier Universitaire (CHU), Nantes, France.
• ² Biology and Pathology Center, Hematology Laboratory, Centre Hospitalier Régional Universitaire (CHRU), Lille, France.
• ³ Hematology Laboratory, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), France.
• ⁴ Hematology, Centre Hospitalier Lyon Sud, Pierre Benite, France.
• ⁵ Hematology, Hôpital Henri Mondor, AP-HP, Créteil, France.
• ⁶ Hematology, Institut Gustave Roussy, Villejuif, France.
• ⁷ EA3518, Institut Universitaire d'Hématologie (IUH), University Paris Diderot, France Hematology, Hôpital Saint-Louis, AP-HP, Paris, France.
• ⁸ EA3518, Institut Universitaire d'Hématologie (IUH), University Paris Diderot, France Hematology Laboratory, Hôpital Saint-Louis, AP-HP, Paris, France.
• ⁹ Cytogenetic Laboratory, Hôpital de Versailles, Le Chesnay, France.
• ¹⁰ Acute Leukemia French Association (ALFA) coordination, Hôpital Saint- Louis, AP-HP, Paris, France.
• ¹¹ Hematology, Hôpital de Versailles, Le Chesnay, France.
• ¹² EA3518, Institut Universitaire d'Hématologie (IUH), University Paris Diderot, France Hematology, Hôpital Avicenne, AP-HP, Bobigny, France.
• ¹³ EA3518, Institut Universitaire d'Hématologie (IUH), University Paris Diderot, France Hematology, Hôpital Saint-Louis, AP-HP, Paris, France herve.dombret@univ-paris-diderot.fr.